Vicarious Surgical Inc. (RBOT) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Vicarious Surgical Inc. (RBOT) has a cash flow conversion efficiency ratio of -0.740x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($-10.42 Million) by net assets ($14.09 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See RBOT net asset quality index to measure how much of total assets are equity-financed.
Vicarious Surgical Inc. - Cash Flow Conversion Efficiency Trend (2019–2024)
This chart illustrates how Vicarious Surgical Inc.'s cash flow conversion efficiency has evolved over time, based on yearly financial data. Check Vicarious Surgical Inc. (RBOT) cash flow quality to evaluate the quality of earnings relative to operating cash generation.
Vicarious Surgical Inc. Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Vicarious Surgical Inc. ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Medivie Therapeutic Ltd
TA:MDVI
|
0.217x |
|
Sleep Number Corp
NASDAQ:SNBR
|
0.012x |
|
MOVEBYBIKE EUROPE AB
F:6ZR
|
-7.892x |
|
SDCL EDGE Acquisition Corporation
NYSE:SEDA
|
-0.009x |
|
Purple Biotech Ltd
TA:KTOV
|
-0.041x |
|
Mongolia Growth Group Ltd.
V:YAK-H
|
-0.015x |
|
SECITS Holding AB (publ)
ST:SECI
|
0.666x |
|
Mastrad
PA:ALMAS
|
0.033x |
Annual Cash Flow Conversion Efficiency for Vicarious Surgical Inc. (2019–2024)
The table below shows the annual cash flow conversion efficiency of Vicarious Surgical Inc. from 2019 to 2024. For the full company profile with market capitalisation and key ratios, see RBOT market cap overview.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | $46.70 Million | $-49.96 Million | -1.070x | -68.21% |
| 2023-12-31 | $97.97 Million | $-62.30 Million | -0.636x | -15.37% |
| 2022-12-31 | $111.05 Million | $-61.21 Million | -0.551x | -37.55% |
| 2021-12-31 | $83.09 Million | $-33.30 Million | -0.401x | +43.90% |
| 2020-12-31 | $16.85 Million | $-12.04 Million | -0.714x | -28.18% |
| 2019-12-31 | $15.63 Million | $-8.71 Million | -0.557x | -- |
About Vicarious Surgical Inc.
Vicarious Surgical Inc. develops and sells single-port surgical robot in the United States. It offers Vicarious Surgical System, a single-port surgical robot that virtually transports surgeons inside the patient to perform invasive surgery. The company was founded in 2014 and is headquartered in Waltham, Massachusetts.